FQ4 and FY 2020 Supplemental Earnings Slides
October 29, 2020 OTCQX: KSHB
FQ4 and FY 2020 Supplemental Earnings Slides October 29, 2020 - - PowerPoint PPT Presentation
FQ4 and FY 2020 Supplemental Earnings Slides October 29, 2020 OTCQX: KSHB IMPORTANT CAUTIONS REGARDING FORWARD LOOKING STATEMENTS 2 A G E N DA 1. FQ4 2020 Highlights and Progress on Strategic Plan 2. FQ4 2020 Financial Summary 3.
October 29, 2020 OTCQX: KSHB
2
3
✓ Net Revenue of $26.5 Million
✚ Represents growth of 19% compared to FQ3 2020 ✚ Exceeded financial guidance of between $25.5 million and $26.0 million ✚ Revenue from Top 100 Customers up 26% sequentially due to growth with larger customers and securing new customers
✓ Strong GAAP Gross Margins of 26% and Continued Strong Non-GAAP Gross Margins of 29%
✚ Returned to 25%+ GAAP gross margins ✚ Sixth consecutive quarter of 20%+ non-GAAP gross margins
✓ Cost-Cutting Reductions Substantially Complete with Cash SG&A of $7.3 million
✚ Cash SG&A down 50%+ from FQ1 to FQ4 2020
✓ Achieved Positive Adjusted EBITDA For First Time in Three Years, Demonstrating Continued Operating Leverage
✚ Improved from ($2.7) million in FQ3 2020 to $1.0 million in FQ4 2020
✓ Positive Cash Flow From Operations For First Time in Three Years
✚ Cash flow from operations improved from ($1.4) million in FQ3 2020 to $0.5 million in FQ4 2020
5
$28.2 $24.6 $18.4 $23.1 $35.0 $30.1 $22.3 $26.5 FQ1 2020 FQ2 2020 FQ3 2020 FQ4 2020
Revenue in millions.
6
Note: The figures in yellow dots represent the percentage of the quarter’s total revenue that is represented by the Top 100 customers by revenue.
81% 82% 82% 87%
QoQ Growth RECREATIONAL STATES 18% MEDICAL STATES 27% TOTAL REVENUE 19% Geography Q4 2020 Revenue % Q4 2020 Revenue QoQ Growth FY 2020 Revenue % FY 2020 Revenue CA $4.2 16.0% 24% $21.4 18.8% MI $2.3 8.7% 40% $7.2 6.3% WA $2.0 7.7% 4% $8.8 7.8% MA $1.5 5.9% 58% $5.0 4.4% CO $1.5 5.8% 1% $8.7 7.6% IL $1.4 5.4% 48% $4.1 3.6% OR $1.0 4.0% 2% $5.9 5.2% NV $0.6 2.4%
$4.5 4.0% ME $0.3 1.2% 3% $1.2 1.1% Other Rec States $0.2 0.7% 19% $0.7 0.6% REC STATES TOTAL $15.3 57.6% 18% $67.6 59.4% Medical States $9.0 34.1% 27% $34.7 30.5% Canada $1.6 6.0%
$8.3 7.3% Other Countries $0.2 0.6% 297% $0.2 0.2% Other* $0.5 1.7% 222% $3.0 2.6% TOTAL REVENUES $26.5 100.0% 19% $113.8 100.0%
Note: Amounts in millions. Total amounts may not add up due to rounding * Other includes states that currently do not have an adult recreational use and/or medical use program 7
Product Categories Q4 2020 Revenue % of Revenue QoQ Growth FY 2020 Revenue % of Revenue Vape $18.3 69.1% 37% $73.7 64.8% Packaging, Papers & Supplies $6.3 23.9%
$27.1 23.8% Energy & Natural Products $1.7 6.4%
$9.3 8.2% Services** $0.1 0.6% NM $3.7 3.2% TOTAL REVENUES $26.5 100.0% 19% $113.8 100%
8 * Amounts in millions. Total amounts may not add up due to rounding ** Services revenue includes sales from hemp trading, retail services and the Hybrid Creative NM = Not Meaningful
Strategy Component Achievements and Milestones Enhanced Focus on Top 100 Customers
Improved KYC and More Profitable Approach with Customer Orders
measures Warehouse Optimization
Grove warehouse
Streamlined Workforce
9
Net Revenue $26.5 $22.3 $47.0 GAAP Gross Profit [Margin] $6.8 [26%] $2.4 [11%]1 $9.4 [20%] Non-GAAP Gross Profit [Margin] 2 $6.9 [29%] $5.7 [28%] $9.6 [20%] Cash SG&A3 $7.3 $7.7 $15.1 Adjusted EBITDA $1.0 ($2.7) ($5.2)
11 1) Gross profit during fiscal Q3 2020 was impacted by several restructuring activities the Company implemented to execute its strategic plan of aligning more closely with its Top 100 customers and achieving positive adjusted
write-down and a $1.0 million purchase order cancellation charge, both driven by the Company’s decision to right size inventory levels and discontinue nearly all of its stock SKUs in order to focus more on custom and best-selling stock inventory demanded by its larger customers. 2) Non-GAAP Gross Profit excludes the impact of certain non-recurring
Gross Profit by Non-GAAP Net Revenue [Net Revenue minus the total amount billed for Section 301 Tariffs]. Non-GAAP Net Revenue for the three months ended August 31, 2020, May 31, 2020, and August 31, 2019 were $24.0 million, $20.4 million, and $47.0 million, respectively. 3) Cash SG&A excludes non-cash expenses, such as bad debt, depreciation, amortization, and stock-based compensation. Amounts in millions. NM = Not Meaningful
12
* Adj. EBITDA for FQ2 2020 included approximately $9.1 million of bad debt expense that the company views as one-time in nature. Note: Amounts in millions.
$35.0 $30.1 $22.3 $26.5 $(6.8) $(14.8) $(2.7) $1.0 FQ1 2020 FQ2 2020 FQ3 2020 FQ4 2020
Revenue
$(5.7)*
Accounts Receivable, Net $9.4 $11.2 $26.0 Inventory, Net $28.0 $24.0 $43.8 Cash $10.5 $11.1 $3.9
13 Amounts in millions.
✚ Additional cross-selling opportunities ✚ Improvement or extension of credit terms to select customers ✚ Secure supply agreements
✚ Investing in salesforce and launching campaigns to secure new MSO customers
15
Amounts in millions.
16
Note: Guidance is effective only as of the date of this presentation. The Company has provided Adjusted EBITDA guidance only on a non-GAAP basis and has not provided a reconciliation of the forward-looking non-GAAP Adjusted EBITDA financial measure to the most directly comparable GAAP financial measure, net income (loss), because not all of the information necessary for a quantitative reconciliation is available to the Company without unreasonable effort. For the same reasons, the Company is unable to address the probable significance of the unavailable information. Forward-looking non-GAAP financial measures provided without the most directly comparable GAAP financial measures may vary materially from the corresponding GAAP financial measures.
Three Months Ended Three Months Ended August 31, 2020 August 31, 2019 Net Revenue $ 26,468 $ 46,972 China tariff surcharge (2,444)
24,024 46,972 GAAP Gross Profit $ 6,837 $ 9,420 GAAP Gross Profit % 26% 20% Purchase order cancellation charges 404
(336) 145 Non-GAAP Gross Profit $ 6,905 $ 9,565 Non-GAAP Gross Profit %* 29% 20% GAAP Net Loss $ (7,288) $ (11,544) Purchase order cancellation charges 404
(336) 145 Non-recurring litigation and consulting costs 666 397 Stock-based compensation 2,934 4,545 Restructuring costs 105 366 Foreign exchange loss 262
Loss on extinguishment of debt 1,651
(1,644) (1,985) Impairment loss on intangible asset 1,156
687 269 Change in fair value of contingent consideration
Non-GAAP Net Loss $ (1,403) $ (7,191)
(
Non-GAAP Net Loss per basic share $ (0.01) $ (0.08) Non-GAAP Net loss per diluted share (0.01) (0.08) Basic Weighted Average Shares Outstanding 124,940 89,091 Diluted Weighted Average Shares Outstanding 124,940 89,091 Non-GAAP Net Loss $ (1,403) $ (7,191) Depreciation and amortization expense 958 789 Interest expense 1,482 1,071 Income tax expense (29) 114 Adjusted EBITDA $ 1,008 $ (5,217)
*Non-GAAP Gross Profit % is calculated by dividing Non-GAAP Gross Profit by Non-GAAP Net Revenue [Net Revenue minus the total amount billed for Section 301 Tariffs]. Non-GAAP Net Revenue for the three months ended August 31, 2020 and August 31, 2019 were $24.0 million and $47.0 million, respectively.